Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

2.

MRI can save rectal cancer patients from surgery, study suggests

3.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

4.

Making informed decisions and managing regret after prostate cancer treatment

5.

What is a "cancer vaccine" and is it the same as a COVID vaccine?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot